Loading patent…
AssigneeKoninklijke Philips N.V.
InventorsRalf Dieter Hoffmann, Monique Stoffels
Estimating the term…
The invention relates to a method of predicting a response of a prostate cancer subject to therapy or of personalizing therapy of a prostate cancer subject, comprising determining or receiving the result of a determination of a first gene expression profile for each of one or more immune defense response genes, of a second gene expression profile for each of one or more T-Cell receptor signaling genes, and of a third gene expression profile for each of one or more PDE4D7 correlated genes, said first, second, and third expression profile(s) being determined in a biological sample obtained from the subject, determining the prediction of the therapy response or the personalization of the therapy based on the first, second, and third gene expression profile(s), and, optionally, providing the prediction or the personalization or a therapy recommendation based on the prediction or the personalization to a medical caregiver or the subject.
A method of predicting a response of a prostate cancer subject to therapy or of personalizing therapy of a prostate cancer subject, comprising:
A non-transitory computer program product comprising instructions which, when the program is executed by a computer, cause the computer to carry out a method comprising:
A diagnostic kit, comprising:
Dependencies are inferred from the claim text.